Semtech Announces First Quarter of Fiscal Year 2023 Results
Semtech Corporation (Nasdaq: SMTC) reported record first-quarter fiscal year 2023 results, with net sales of $202.1 million, up 6.1% sequentially and 18.7% year-over-year. GAAP gross margin reached 64.4%, while non-GAAP gross margin was 64.8%. The company achieved diluted earnings per share of $0.59 GAAP and $0.80 non-GAAP. The Wireless and Sensing products group saw a 15.0% year-over-year sales growth. For Q2 FY2023, Semtech forecasts net sales between $203.0 million to $213.0 million and diluted EPS of $0.79 to $0.89.
- Record net sales of $202.1 million, a 6.1% sequential increase.
- GAAP gross margin of 64.4%, up 30bps sequentially.
- Non-GAAP gross margin reached 64.8%, showing a 30bps increase.
- Record diluted earnings per share at $0.59 GAAP and $0.80 non-GAAP.
- Growth in Wireless and Sensing products sales by 15.0% year-over-year.
- Uncertain impact from supply chain constraints and COVID-19 on future results.
Highlights for the First Quarter of Fiscal Year 2023
-
Record net sales of
, an increase of$202.1 million 6.1% sequentially and18.7% year-over-year -
Record GAAP gross margin of
64.4% grew 30bps sequentially and 290bps year-over-year -
Record non-GAAP gross margin of
64.8% grew 30bps sequentially and 280bps year-over-year -
Record GAAP and non-GAAP diluted earnings per share of
and$0.59 , respectively$0.80 -
Record Wireless and Sensing products group net sales grew8.6% sequentially and15.0% year-over-year driven by record LoRa®-enabled sales -
Record Signal Integrity products group net sales grew
4.4% sequentially and18.9% year-over-year driven by strong hyperscale data center sales and 10G and 2.5G PON sales -
Protection products group net sales grew
5.5% sequentially and23.0% year-over-year driven by strong Industrial and Automotive product sales -
Operating cash flow of
or$50.1 million 24.8% of Q1 FY2023 net sales -
Repurchased 762,093 shares for
$50.0 million
Results on a GAAP basis for the First Fiscal Quarter 2023
-
Net sales were
$202.1 million -
GAAP Gross margin was
64.4% -
GAAP SG&A expense was
$43.4 million -
GAAP R&D expense was
$38.8 million -
GAAP Operating margin was
23.3% -
GAAP Net income attributable to common stockholders was
or$38.0 million diluted earnings per share$0.59
To facilitate a complete understanding of comparable financial performance between periods, the Company also presents performance results that exclude certain non-cash items and items that are not considered reflective of the Company’s core results over time. These non-GAAP financial measures exclude certain items and are described below under “Non-GAAP Financial Measures.”
Results on a Non-GAAP basis for the First Fiscal Quarter 2023 (see the list of non-GAAP financial measures and the reconciliation of these measures to the most comparable GAAP measures set forth in the tables below under "Supplemental Information: Reconciliation of GAAP to Non-GAAP Results")
-
Non-GAAP Gross margin was
64.8% -
Non-GAAP SG&A expense was
$36.1 million -
Non-GAAP R&D expense was
$34.8 million -
Non-GAAP Operating margin was
29.8% -
Non-GAAP Net income attributable to common stockholders was
or$51.8 million diluted earnings per share$0.80
Second Fiscal Quarter 2023 Outlook
Both the GAAP and non-GAAP second fiscal quarter 2023 outlook below take into account the impact of the divestiture of the Company's high reliability discrete diodes and assemblies business and, based on the Company's current estimates, the uncertain, but potential negative impact to the Company of the current supply chain constraints and any associated disruptions, and the ongoing COVID-19 pandemic on global economic conditions and on the Company's business operations, net sales and operating results, as well as export restrictions. The Company is unable to predict the full impact such challenges may have on its future results of operations.
GAAP Second Fiscal Quarter 2023 Outlook
-
Net sales are expected to be in the range of
to$203.0 million $213.0 million -
GAAP Gross margin is expected to be in the range of
64.1% to65.5% -
GAAP SG&A expense is expected to be in the range of
to$45.1 million $46.1 million -
GAAP R&D expense is expected to be in the range of
to$39.5 million $40.5 million -
GAAP Intangible amortization expense is expected to be approximately
$1.0 million -
GAAP Interest and other expense, net is expected to be approximately
$1.5 million -
GAAP Effective tax rate is expected to be in the range of
17% to19% -
GAAP Diluted earnings per share is expected to be in the range of
to$0.79 $0.89 - Fully-diluted share count is expected to be approximately 64.0 million shares
-
Share-based compensation is expected to be approximately
, categorized as follows:$12.3 million cost of sales,$0.8 million SG&A, and$7.0 million R&D$4.5 million -
Capital expenditures are expected to be approximately
$10.7 million -
Depreciation expense is expected to be approximately
$6.4 million
Non-GAAP Second Fiscal Quarter 2023 Outlook (see the list of non-GAAP financial measures and the reconciliation of these measures to the most comparable GAAP measures set forth in the tables below under "Reconciliation of GAAP to Non-GAAP Outlook")
-
Non-GAAP Gross margin is expected to be in the range of
64.5% to65.9% -
Non-GAAP SG&A expense is expected to be in the range of
to$36.0 million $37.0 million -
Non-GAAP R&D expense is expected to be in the range of
to$35.0 million $36.0 million -
Non-GAAP normalized tax rate for fiscal year 2023 is expected to be approximately
12% -
Non-GAAP Diluted earnings per share is expected to be in the range of
to$0.80 $0.90
Webcast and Conference Call
Semtech will be hosting a conference call today to discuss its first fiscal quarter 2023 results at
Non-GAAP Financial Measures
To supplement the Company's consolidated financial statements prepared in accordance with GAAP, this release includes a presentation of select non-GAAP financial measures. The Company’s non-GAAP measures of gross margin, SG&A expense, R&D expense, operating margin, net income attributable to common stockholders, diluted earnings per share and normalized tax rate exclude the following items, if any:
- Share-based compensation
- Amortization of purchased intangibles, impairments and credit loss reserves
- Restructuring, transaction and other acquisition or disposition-related gains or losses
- Litigation expenses or dispute settlement charges or gains
- Cumulative other reserves associated with historical activity including environmental and pension
- Equity in net gains or losses of equity method investments
- Loss on early extinguishment of debt
- Interest income from debt investments
- Changes in the fair value of contingent earn-out obligations
To provide additional insight into the Company's second quarter outlook, this release also includes a presentation of forward-looking non-GAAP financial measures. Management believes that the presentation of these non-GAAP measures provides useful information to investors regarding the Company’s financial condition and results of operations. These non-GAAP financial measures are adjusted to exclude the items identified above because such items are either operating expenses that would not otherwise have been incurred by the Company in the normal course of the Company’s business operations, or are not reflective of the Company’s core results over time. These excluded items may include recurring as well as non-recurring items, and no inference should be made that all of these adjustments, charges, costs or expenses are unusual, infrequent or non-recurring. For example: certain restructuring and integration-related expenses (which consist of employee termination costs, facility closure or lease termination costs, and contract termination costs) may be considered recurring given the Company’s ongoing efforts to be more cost effective and efficient; certain acquisition and disposition-related adjustments or expenses may be deemed recurring given the Company's regular evaluation of potential transactions and investments; and certain litigation expenses or dispute settlement charges or gains (which may include estimated losses for which the Company may have established a reserve, as well as any actual settlements, judgments, or other resolutions against, or in favor of, the Company related to litigation, arbitration, disputes or similar matters, and insurance recoveries received by the Company related to such matters) may be viewed as recurring given that the Company may from time to time be involved in, and may resolve, litigation, arbitration, disputes, and similar matters.
Notwithstanding that certain adjustments, charges, costs or expenses may be considered recurring, in order to provide meaningful comparisons, the Company believes that it is appropriate to exclude such items because they are not reflective of the Company's core results and tend to vary based on timing, frequency and magnitude.
These non-GAAP financial measures are provided to enhance the user's overall understanding of the Company's comparable financial performance between periods. In addition, the Company’s management generally excludes the items noted above when managing and evaluating the performance of the business. The financial statements provided with this release include reconciliations of these non-GAAP financial measures to their most comparable GAAP measures for the first and fourth quarters of fiscal year 2022 and the first quarter of fiscal year 2023, along with a reconciliation of forward-looking non-GAAP measures (other than the non-GAAP normalized tax rate) to their most comparable GAAP measures for the second quarter of fiscal year 2023. Beginning with fiscal year 2022, the Company adopted a full-year, normalized tax rate for the computation of the non-GAAP income tax provision in order to provide better comparability across the interim reporting periods by reducing the quarterly variability in non-GAAP tax rates that can occur throughout the year. In estimating the full-year non-GAAP normalized tax rate, the Company utilized a full-year financial projection that considers multiple factors such as changes to the Company’s current operating structure, existing positions in various tax jurisdictions, the effect of key tax law changes, and other significant tax matters to the extent they are applicable to the full fiscal year financial projection. In addition to the adjustments described above, this normalized tax rate excludes the impact of share-based awards and the amortization of acquisition-related intangible assets. For fiscal year 2023, the Company’s projected non-GAAP normalized tax rate is
Forward-Looking and Cautionary Statements
This press release contains "forward-looking statements" within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, as amended, based on the Company’s current expectations, estimates and projections about its operations, industry, financial condition, performance, results of operations, and liquidity. Forward-looking statements are statements other than historical information or statements of current condition and relate to matters such as future financial performance including the second quarter of fiscal year 2023 outlook and our expectations for growth and strong financial results in fiscal year 2023; the potential for a negative impact associated with the current supply chain constraints and any associated disruptions; the potential for a negative impact of the COVID-19 pandemic on global economic conditions and on the Company's business operations, net sales and operating results; the Company’s expectations concerning the negative impact on the Company’s results of operations from its inability to ship certain products and provide certain support services due to the export restrictions; future operational performance; the anticipated impact of specific items on future earnings; and the Company’s plans, objectives and expectations. Statements containing words such as “may,” “believes,” “anticipates,” “expects,” “intends,” “plans,” “projects,” “estimates,” “should,” “will,” “designed to,” “projections,” or “business outlook,” or other similar expressions constitute forward-looking statements.
Forward-looking statements involve known and unknown risks and uncertainties that could cause actual results and events to differ materially from those projected. Potential factors that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to: the uncertainty surrounding the impact and duration of supply chain constraints and any associated disruptions; the uncertainty surrounding the impact and duration of the COVID-19 pandemic; export restrictions and laws affecting the Company's trade and investments, and tariffs or the occurrence of trade wars; worldwide economic and political disruptions as a result of the current conflict between
About Semtech
Semtech, the Semtech logo and LoRa are registered trademarks or service marks of
SMTC-F
|
|||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME |
|||||||||||
(in thousands, except per share data) |
|||||||||||
(unaudited) |
|||||||||||
|
Three Months Ended |
||||||||||
|
|
|
|
|
|
||||||
|
Q123 |
|
Q422 |
|
Q122 |
||||||
Net sales |
$ |
202,149 |
|
|
$ |
190,550 |
|
|
$ |
170,372 |
|
Cost of sales |
|
71,896 |
|
|
|
68,451 |
|
|
|
65,511 |
|
Gross profit |
|
130,253 |
|
|
|
122,099 |
|
|
|
104,861 |
|
Operating costs and expenses: |
|
|
|
|
|
||||||
Selling, general and administrative |
|
43,364 |
|
|
|
39,808 |
|
|
|
38,804 |
|
Product development and engineering |
|
38,789 |
|
|
|
38,292 |
|
|
|
36,790 |
|
Intangible amortization |
|
1,048 |
|
|
|
1,048 |
|
|
|
1,298 |
|
Changes in the fair value of contingent earn-out obligations |
|
— |
|
|
|
(13 |
) |
|
|
— |
|
Total operating costs and expenses |
|
83,201 |
|
|
|
79,135 |
|
|
|
76,892 |
|
Operating income |
|
47,052 |
|
|
|
42,964 |
|
|
|
27,969 |
|
Interest expense |
|
(1,197 |
) |
|
|
(1,474 |
) |
|
|
(1,199 |
) |
Non-operating income, net |
|
262 |
|
|
|
68 |
|
|
|
94 |
|
Investment impairments and credit loss reserves |
|
(24 |
) |
|
|
(407 |
) |
|
|
(246 |
) |
Income before taxes and equity in net gains of equity method investments |
|
46,093 |
|
|
|
41,151 |
|
|
|
26,618 |
|
Provision for taxes |
|
8,069 |
|
|
|
6,360 |
|
|
|
3,198 |
|
Net income before equity in net gains of equity method investments |
|
38,024 |
|
|
|
34,791 |
|
|
|
23,420 |
|
Equity in net gains of equity method investments |
|
24 |
|
|
|
— |
|
|
|
78 |
|
Net income |
|
38,048 |
|
|
|
34,791 |
|
|
|
23,498 |
|
Net loss attributable to noncontrolling interest |
|
(1 |
) |
|
|
(13 |
) |
|
|
(2 |
) |
Net income attributable to common stockholders |
$ |
38,049 |
|
|
$ |
34,804 |
|
|
$ |
23,500 |
|
|
|
|
|
|
|
||||||
Earnings per share: |
|
|
|
|
|
||||||
Basic |
$ |
0.59 |
|
|
$ |
0.54 |
|
|
$ |
0.36 |
|
Diluted |
$ |
0.59 |
|
|
$ |
0.53 |
|
|
$ |
0.36 |
|
|
|
|
|
|
|
||||||
Weighted average number of shares used in computing earnings per share: |
|
|
|
|
|
||||||
Basic |
|
63,950 |
|
|
|
64,289 |
|
|
|
65,089 |
|
Diluted |
|
64,553 |
|
|
|
65,235 |
|
|
|
66,110 |
|
|
|||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
|||||
(in thousands) |
|||||
(unaudited) |
|||||
|
|
|
|
||
ASSETS |
|
|
|
||
Current assets: |
|
|
|
||
Cash and cash equivalents |
$ |
275,184 |
|
$ |
279,601 |
Accounts receivable, net |
|
66,360 |
|
|
71,507 |
Inventories |
|
106,901 |
|
|
114,003 |
Prepaid taxes |
|
2,442 |
|
|
5,983 |
Assets held for sale |
|
9,065 |
|
|
— |
Other current assets |
|
35,471 |
|
|
31,201 |
Total current assets |
|
495,423 |
|
|
502,295 |
Non-current assets: |
|
|
|
||
Property, plant and equipment, net |
|
133,590 |
|
|
134,940 |
Deferred tax assets |
|
25,643 |
|
|
27,803 |
|
|
350,306 |
|
|
351,141 |
Other intangible assets, net |
|
5,756 |
|
|
6,804 |
Other assets |
|
105,198 |
|
|
107,928 |
Total assets |
$ |
1,115,916 |
|
$ |
1,130,911 |
|
|
|
|
||
LIABILITIES AND EQUITY |
|
|
|
||
Current liabilities: |
|
|
|
||
Accounts payable |
$ |
48,381 |
|
$ |
50,695 |
Accrued liabilities |
|
60,793 |
|
|
77,704 |
Liabilities held for sale |
|
1,242 |
|
|
— |
Total current liabilities |
|
110,416 |
|
|
128,399 |
Non-current liabilities: |
|
|
|
||
Deferred tax liabilities |
|
1,066 |
|
|
1,132 |
Long term debt |
|
181,797 |
|
|
171,676 |
Other long-term liabilities |
|
87,464 |
|
|
91,929 |
Stockholders’ equity |
|
734,983 |
|
|
737,584 |
Noncontrolling interest |
|
190 |
|
|
191 |
Total liabilities & equity |
$ |
1,115,916 |
|
$ |
1,130,911 |
|
|||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS AND SUPPLEMENTAL INFORMATION |
|||||||||||
(in thousands) |
|||||||||||
(unaudited) |
|||||||||||
|
Three Months Ended |
|
|
||||||||
|
|
|
|
|
|
||||||
Net income |
$ |
38,048 |
|
|
$ |
23,498 |
|
|
|
||
|
|
|
|
|
|
||||||
Net cash provided by operations |
|
50,051 |
|
|
|
32,585 |
|
|
|
||
Net cash used in investing activities |
|
(10,315 |
) |
|
|
(8,655 |
) |
|
|
||
Net cash used in financing activities |
|
(44,153 |
) |
|
|
(34,602 |
) |
|
|
||
Net decrease in cash and cash equivalents |
|
(4,417 |
) |
|
|
(10,672 |
) |
|
|
||
Cash and cash equivalents at beginning of period |
|
279,601 |
|
|
|
268,891 |
|
|
|
||
Cash and cash equivalents at end of period |
$ |
275,184 |
|
|
$ |
258,219 |
|
|
|
||
|
|
|
|
|
|
||||||
|
Three Months Ended |
||||||||||
|
|
|
|
|
|
||||||
|
Q123 |
|
Q422 |
|
Q122 |
||||||
Free Cash Flow: |
|
|
|
|
|
||||||
Cash Flow from Operations |
$ |
50,051 |
|
|
$ |
50,986 |
|
|
$ |
32,585 |
|
Net Capital Expenditures |
|
(8,315 |
) |
|
|
(8,100 |
) |
|
|
(5,760 |
) |
Free Cash Flow |
$ |
41,736 |
|
|
$ |
42,886 |
|
|
$ |
26,825 |
|
|
|||||||||||
SUPPLEMENTAL INFORMATION: RECONCILIATION OF GAAP TO NON-GAAP RESULTS |
|||||||||||
(in thousands, except per share data) |
|||||||||||
(unaudited) |
|||||||||||
|
Three Months Ended |
||||||||||
|
|
|
|
|
|
||||||
|
Q123 |
|
Q422 |
|
Q122 |
||||||
Gross Margin–GAAP |
|
64.4 |
% |
|
|
64.1 |
% |
|
|
61.5 |
% |
Share-based compensation |
|
0.4 |
% |
|
|
0.4 |
% |
|
|
0.5 |
% |
Adjusted Gross Margin (Non-GAAP) |
|
64.8 |
% |
|
|
64.5 |
% |
|
|
62.0 |
% |
|
|
|
|
|
|
||||||
|
Three Months Ended |
||||||||||
|
|
|
|
|
|
||||||
|
Q123 |
|
Q422 |
|
Q122 |
||||||
Selling, general and administrative–GAAP |
$ |
43,364 |
|
|
$ |
39,808 |
|
|
$ |
38,804 |
|
Share-based compensation |
|
(6,132 |
) |
|
|
(5,593 |
) |
|
|
(7,359 |
) |
Transaction and integration related (costs) recoveries, net |
|
(495 |
) |
|
|
(204 |
) |
|
|
177 |
|
Restructuring and other reserves, net |
|
(500 |
) |
|
|
— |
|
|
|
— |
|
Litigation (costs) recoveries, net |
|
(181 |
) |
|
|
152 |
|
|
|
(540 |
) |
Adjusted selling, general and administrative (Non-GAAP) |
$ |
36,056 |
|
|
$ |
34,163 |
|
|
$ |
31,082 |
|
|
|
|
|
|
|
||||||
|
Three Months Ended |
||||||||||
|
|
|
|
|
|
||||||
|
Q123 |
|
Q422 |
|
Q122 |
||||||
Product development and engineering–GAAP |
$ |
38,789 |
|
|
$ |
38,292 |
|
|
$ |
36,790 |
|
Share-based compensation |
|
(3,986 |
) |
|
|
(4,110 |
) |
|
|
(3,762 |
) |
Transaction and integration related recoveries, net |
|
— |
|
|
|
329 |
|
|
|
— |
|
Adjusted product development and engineering (Non-GAAP) |
$ |
34,803 |
|
|
$ |
34,511 |
|
|
$ |
33,028 |
|
|
|
|
|
|
|
||||||
|
Three Months Ended |
||||||||||
|
|
|
|
|
|
||||||
|
Q123 |
|
Q422 |
|
Q122 |
||||||
Operating Margin–GAAP |
|
23.3 |
% |
|
|
22.5 |
% |
|
|
16.4 |
% |
Share-based compensation |
|
5.5 |
% |
|
|
5.6 |
% |
|
|
6.9 |
% |
Intangible amortization |
|
0.5 |
% |
|
|
0.6 |
% |
|
|
0.8 |
% |
Transaction and integration related costs (recoveries), net |
|
0.2 |
% |
|
|
(0.1 |
)% |
|
|
(0.1 |
)% |
Restructuring and other reserves, net |
|
0.2 |
% |
|
|
— |
% |
|
|
— |
% |
Litigation costs (recoveries), net |
|
0.1 |
% |
|
|
(0.1 |
)% |
|
|
0.3 |
% |
Adjusted Operating Margin (Non-GAAP) |
|
29.8 |
% |
|
|
28.5 |
% |
|
|
24.3 |
% |
|
|||||||||||
SUPPLEMENTAL INFORMATION: RECONCILIATION OF GAAP TO NON-GAAP RESULTS (CONTINUED) |
|||||||||||
(in thousands, except per share data) |
|||||||||||
(unaudited) |
|||||||||||
|
Three Months Ended |
||||||||||
|
|
|
|
|
|
||||||
|
Q123 |
|
Q422 |
|
Q122 |
||||||
GAAP net income attributable to common stockholders |
$ |
38,049 |
|
|
$ |
34,804 |
|
|
$ |
23,500 |
|
Adjustments to GAAP net income attributable to common stockholders: |
|
|
|
|
|
||||||
Share-based compensation |
|
10,893 |
|
|
|
10,492 |
|
|
|
11,839 |
|
Intangible amortization |
|
1,048 |
|
|
|
1,048 |
|
|
|
1,298 |
|
Transaction and integration related costs (recoveries), net |
|
495 |
|
|
|
(125 |
) |
|
|
(177 |
) |
Restructuring and other reserves |
|
500 |
|
|
|
— |
|
|
|
— |
|
Litigation costs (recoveries), net |
|
181 |
|
|
|
(152 |
) |
|
|
540 |
|
Changes in the fair value of contingent earn-out obligations |
|
— |
|
|
|
(13 |
) |
|
|
— |
|
Investment (gains) losses, reserves and impairments, net |
|
(324 |
) |
|
|
65 |
|
|
|
(84 |
) |
Total Non-GAAP adjustments before taxes |
|
12,793 |
|
|
|
11,315 |
|
|
|
13,416 |
|
Associated tax effect |
|
1,003 |
|
|
|
(460 |
) |
|
|
(2,006 |
) |
Equity in net gains of equity method investments |
|
(24 |
) |
|
|
— |
|
|
|
(78 |
) |
Total of supplemental information, net of taxes |
|
13,772 |
|
|
|
10,855 |
|
|
|
11,332 |
|
Non-GAAP net income attributable to common stockholders |
$ |
51,821 |
|
|
$ |
45,659 |
|
|
$ |
34,832 |
|
|
|
|
|
|
|
||||||
GAAP diluted earnings per share |
$ |
0.59 |
|
|
$ |
0.53 |
|
|
$ |
0.36 |
|
Adjustments per above |
|
0.21 |
|
|
|
0.17 |
|
|
|
0.17 |
|
Non-GAAP diluted earnings per share |
$ |
0.80 |
|
|
$ |
0.70 |
|
|
$ |
0.53 |
|
|
||||||||
RECONCILIATION OF GAAP TO NON-GAAP OUTLOOK |
||||||||
Second Quarter of Fiscal Year 2023 Outlook |
||||||||
(in millions, except per share data) |
||||||||
|
|
Q2 FY23 Outlook |
||||||
|
|
|
||||||
|
|
Low |
|
High |
||||
Gross Margin–GAAP |
|
|
64.1 |
% |
|
|
65.5 |
% |
Share-based compensation |
|
|
0.4 |
% |
|
|
0.4 |
% |
Adjusted Gross Margin (Non-GAAP) |
|
|
64.5 |
% |
|
|
65.9 |
% |
|
|
|
|
|
||||
|
|
Low |
|
High |
||||
Selling, general and administrative–GAAP |
|
$ |
45.1 |
|
|
$ |
46.1 |
|
Share-based compensation |
|
|
(7.0 |
) |
|
|
(7.0 |
) |
Transaction and integration related |
|
|
(2.1 |
) |
|
|
(2.1 |
) |
Adjusted selling, general and administrative (Non-GAAP) |
|
$ |
36.0 |
|
|
$ |
37.0 |
|
|
|
|
|
|
||||
|
|
Low |
|
High |
||||
Product development and engineering–GAAP |
|
$ |
39.5 |
|
|
$ |
40.5 |
|
Share-based compensation |
|
|
(4.5 |
) |
|
|
(4.5 |
) |
Adjusted product development and engineering (Non-GAAP) |
|
$ |
35.0 |
|
|
$ |
36.0 |
|
|
|
|
|
|
||||
|
|
Low |
|
High |
||||
Gain on sale of business–GAAP |
|
$ |
(19.0 |
) |
|
$ |
(19.0 |
) |
Gain on sale of business |
|
|
19.0 |
|
|
|
19.0 |
|
Adjusted gain on sale of business (Non-GAAP) |
|
$ |
— |
|
|
$ |
— |
|
|
|
|
|
|
||||
|
|
Low |
|
High |
||||
Diluted earnings per share–GAAP |
|
$ |
0.79 |
|
|
$ |
0.89 |
|
Share-based compensation |
|
|
0.19 |
|
|
|
0.19 |
|
Transaction, restructuring, and acquisition related expenses |
|
|
0.03 |
|
|
|
0.03 |
|
Amortization of acquired intangibles |
|
|
0.02 |
|
|
|
0.02 |
|
Gain on sale of business |
|
|
(0.30 |
) |
|
|
(0.30 |
) |
Associated tax effect |
|
|
0.07 |
|
|
|
0.07 |
|
Adjusted diluted earnings per share (Non-GAAP) |
|
$ |
0.80 |
|
|
$ |
0.90 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20220601006105/en/
(805) 480-2004
webir@semtech.com
Source:
FAQ
What were Semtech's earnings for Q1 FY2023?
What is the net sales forecast for Semtech in Q2 FY2023?
What is Semtech's gross margin for Q1 FY2023?